Insider Trading Activity Tenet Healthcare Corp (NYSE:THC) – Director Sold 39,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For Tenet Healthcare Corp (NYSE:THC)

George Fredrick Smitherman , Director of Tenet Healthcare Corp (NYSE:THC) reportedly Sold 39,000 shares of the company’s stock at an average price of 0.39 for a total transaction amount of $15,210.00 SEC Form

Insider Trading History For Tenet Healthcare Corp (NYSE:THC)

On 9/17/2012 Glenview Capital Management Ll, Major Shareholder, bought 750,000 with an average share price of $5.75 per share and the total transaction amounting to $4,312,500.00.

On 10/16/2012 Glenview Capital Management Ll, Major Shareholder, bought 433,383 with an average share price of $23.98 per share and the total transaction amounting to $10,392,524.34.

On 10/19/2012 Glenview Capital Management Ll, Major Shareholder, bought 200,000 with an average share price of $23.53 per share and the total transaction amounting to $4,706,000.00.

On 3/4/2013 Trevor Fetter, CEO, sold 138,255 with an average share price of $39.39 per share and the total transaction amounting to $5,445,864.45.

On 3/5/2013 Edward A Kangas, Chairman, sold 7,000 with an average share price of $39.88 per share and the total transaction amounting to $279,160.00.

On 5/14/2013 Glenview Capital Management, L, Major Shareholder, sold 4,000,000 with an average share price of $47.75 per share and the total transaction amounting to $191,000,000.00.

On 9/19/2013 John Ellis Bush, Director, sold 8,291 with an average share price of $42.90 per share and the total transaction amounting to $355,683.90.

Analyst Ratings History For Tenet Healthcare Corp (NYSE:THC)

On 2/26/2016 BMO Capital Markets Lower Price Target of rating Outperform with a price target of $55.00 to $38.00
On 4/13/2016 Susquehanna Bancshares Upgraded rating Neutral to Positive with a price target of $38.00
On 5/16/2016 Sterne Agee CRT Reiterated Rating Buy
On 6/13/2016 Ladenburg Thalmann Financial Services Upgraded rating Not Rated to Underperform
On 8/19/2016 Barclays Reiterated Rating Buy with a price target of $39.00
On 10/25/2016 Wolfe Research Initiated Coverage of rating Market Perform
On 11/9/2016 Bank of America Downgraded rating Buy to Neutral with a price target of $32.00 to $25.00

Recent Trading Activity for Tenet Healthcare Corp (NYSE:THC)
Shares of Tenet Healthcare Corp closed the previous trading session at 18.28 +0.00 0.00% with 16.950000762939453 shares trading hands.